Found 463 results in Expert Content

Summary: In this webinar, experts discuss the key drivers and challenges of orphan drug development and manufacturing.

Summary: Learn how innovative trial designs, on-demand manufacturing, real-time clinical data-based dose adjustments, and partnering with experienced formulators and Contract Research Organizations (CROs) can enable faster, better decision making during phase 1 clinical trials.

Summary: A recent survey explored the attitudes and changing perceptions of experienced Phase 1 development professionals toward development challenges and available solutions.

Summary: Mike Riley, President, Catalent Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from Catalent’s award-winning SMARTag® ADC platform.

Summary: In this webinar Endpoints Editor, John Carroll sits down with Catalent CEO, Alessandro Maselli to talk about the year ahead, offering their projections for what 2023 holds in store for the biopharma industry

Summary: In this article experts shared their insights on developing intranasal products and scaling them for commercial supply.

In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.

Summary: In this article, Mark Ignaczak provides insight into the history of nasal drug delivery and the advantages of the nasal delivery route.

Summary: In this eBook, learn more about how the timely progression of a drug candidate into clinical trials is critical for pharmaceutical companies seeking to bring new products to the market.

In this webinar experts will discuss the challenges cell and gene therapy innovators face and how experts resolve these barriers through adopting technology and strategy that drive an optimized plasmid production process and supply.